KIT and squamous cell carcinoma: CD5 and CD117 immunohistochemistry should be considered in squamous cell carcinomas and undifferentiated carcinomas involving the salivary glands, especially when a distant primary tumor is not clinically evident and they display morphologic resemblance to thymic carcinoma.